Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 31, 2008

Primary Completion Date

May 31, 2009

Study Completion Date

July 31, 2010

Conditions
Percutaneous Coronary Intervention
Interventions
DRUG

Pitavastatin

4mg daily for 5-7 days before Percutaneous Coronary Intervention(PCI) and 4mg daily for 28 days after PCI

DRUG

Pitavastatin

4mg daily for 28 days after PCI

Trial Locations (1)

Unknown

Catholic University of Korea Kangnam St. Mary's Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY